Integrated Diagnostics Holdings PLC Notice of AGM

RNS Number : 6540M

Integrated Diagnostics Holdings PLC

30 April 2024

 

30 April 2024

 

Integrated Diagnostics Holdings plc

 (the "Company")

 

Notice of Annual General Meeting 2024

 

Following the publication of the 2023 Annual Report and Accounts ("2023 Annual Report") on 28 March 2024 (RNS Number: 6093I), the Company has today posted the following documents to shareholders:

 

·    2023 Annual Report;

·    Notice of 2024 Annual General Meeting (AGM); and

·    Letter of Availability.

 

In accordance with Listing Rule 14.3.6, the 2023 Annual Report and Notice of AGM are available for inspection via the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

 

The Company's AGM is scheduled to be held at 3:00 p.m. BST on Wednesday, 29 May 2024 at 2 More London Riverside, London, SE1 2JT.

 

If you are unable to attend the AGM but would like to vote on the resolutions, kindly request to submit your proxy vote online at www.signalshares.com or in accordance with the instructions set out in note 2 of the Explanatory Notes to the Notice of AGM which can be found on the Company's website https://www.idhcorp.com/.

 

Shareholders wishing to access the dial-in facility or submit questions are asked to email  [e-mail] by close of business on Wednesday, 22 May 2024.

 

 

   

For further information please contact:

 

Integrated Diagnostics Holdings plc
Tarek Yehia Investor Relations Director	[phone]
Company Secretary Link Company Matters Limited	[e-mail]

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

NOASDFFDSELSEFL